CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Series A Preferred	Series B1 Preferred Stock	Series B Preferred Stock	Common Stock	Common Stock Series A Preferred	Common Stock Series B1 Preferred Stock	Common Stock Series B Preferred Stock	Preferred stock	Preferred stock Series A Preferred	Preferred stock Series C Preferred	Additional Paid-In Capital	Additional Paid-In Capital Series B1 Preferred Stock	Additional Paid-In Capital Series B Preferred Stock	Retained Earnings	Retained Earnings Series B Preferred Stock	Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2020					45,555,000					420,000	0
Beginning balance at Dec. 31, 2020	$ 5,925				$ 46					$ 0	$ 0	$ 94,570			$ (90,009)		$ 1,318
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)					23,000		1,080,000
Exercise of options/ B1 warrants	0		$ 2,758		$ 0		$ 1					0	$ 2,757
Share based compensation expense	150											150
Exchanges of Series B Preferred stock to common (in shares)								2,359,000
Exchanges of Series B Preferred stock to common				$ 4,746				$ 2						$ 4,114		$ 630
Conversion of Series B Preferred stock to common (in shares)								638,000
Conversion of Series B Preferred stock to common				1,979				$ 1						1,978
Conversion of Series B1 Preferred stock to common (in shares)							2,087,000
Conversion of Series B1 Preferred stock to common			3,256				$ 2						3,254
Dividends on Series B and B1	(372)														(372)
Accretion of discount on Series B and B1	(224)														(224)
Accretion of redeemable non-controlling interest to redemption value	(373)														(373)
Net income (loss)	2,965														974		1,991
Less: amount attributable to redeemable non-controlling interest	(1,542)																(1,542)
Ending balance (in shares) at Mar. 31, 2021					51,742,000					420,000	0
Ending balance at Mar. 31, 2021	19,268				$ 52					$ 0	$ 0	106,823			(89,374)		1,767
Beginning balance (in shares) at Dec. 31, 2020					45,555,000					420,000	0
Beginning balance at Dec. 31, 2020	5,925				$ 46					$ 0	$ 0	94,570			(90,009)		1,318
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)					500,000
Net income (loss)	(12,991)
Ending balance (in shares) at Jun. 30, 2021					59,909,000					392,000	0
Ending balance at Jun. 30, 2021	18,503				$ 60					$ 0	$ 0	125,804			(109,420)		2,059
Beginning balance (in shares) at Mar. 31, 2021					51,742,000					420,000	0
Beginning balance at Mar. 31, 2021	19,268				$ 52					$ 0	$ 0	106,823			(89,374)		1,767
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)					505,000		157,000
Exercise of options/ B1 warrants	229		1,634		$ 0		$ 0					229	1,634
Exercise of options to common- unissued	475											475
Leverage Lubricants contribution	(13)																(13)
Exercise of B1 warrants-unissued	1,186											1,186
Share based compensation expense	205											205
Conversion of Series A Preferred stock to common (in shares)					28,000					(28,000)
Conversion of Series A Preferred stock to common	0
Conversion of Series B Preferred stock to common (in shares)								1,842,000
Conversion of Series B Preferred stock to common				5,709				$ 2						5,707
Conversion of Series B Preferred stock to common-unissued				$ 760										$ 760
Conversion of Series B1 Preferred stock to common (in shares)							5,635,000
Conversion of Series B1 Preferred stock to common			8,791				$ 6						8,785
Accretion of discount on Series B and B1	(284)														(284)
Accretion of redeemable non-controlling interest to redemption value	(387)														(387)
Net income (loss)	(15,957)														(19,375)		3,418
Less: amount attributable to redeemable non-controlling interest	(3,113)																(3,113)
Ending balance (in shares) at Jun. 30, 2021					59,909,000					392,000	0
Ending balance at Jun. 30, 2021	18,503				$ 60					$ 0	$ 0	125,804			(109,420)		2,059
Beginning balance (in shares) at Dec. 31, 2021					63,288,000					386,000	0
Beginning balance at Dec. 31, 2021	30,066				$ 63					$ 0	$ 0	138,620			(110,614)		1,997
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)					60,000		1,113,000
Exercise of options/ B1 warrants	76		$ 0				$ 1					76	$ (1)
Share based compensation expense	250											250
Conversion of Series A Preferred stock to common (in shares)						5,000				(5,000)
Conversion of Series A Preferred stock to common		$ 0
Reclassification of derivative liabilities	78,789											78,789
Accretion of redeemable non-controlling interest to redemption value	(422)														(422)
Net income (loss)	(808)														(4,547)		3,739
Less: amount attributable to redeemable non-controlling interest	(3,769)																(3,769)
Ending balance (in shares) at Mar. 31, 2022					64,466,000					381,000	0
Ending balance at Mar. 31, 2022	104,182				$ 64					$ 0	$ 0	217,734			(115,583)		1,967
Beginning balance (in shares) at Dec. 31, 2021					63,288,000					386,000	0
Beginning balance at Dec. 31, 2021	30,066				$ 63					$ 0	$ 0	138,620			(110,614)		1,997
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)					600,000
Conversion of Series A Preferred stock to common (in shares)					10,200,000
Conversion of Series A Preferred stock to common	59,800
Net income (loss)	(64,591)
Ending balance (in shares) at Jun. 30, 2022					75,509,000				0		0
Ending balance at Jun. 30, 2022	97,695				$ 76				$ 0		$ 0	278,455			(182,588)		1,752
Beginning balance (in shares) at Mar. 31, 2022					64,466,000					381,000	0
Beginning balance at Mar. 31, 2022	104,182				$ 64					$ 0	$ 0	217,734			(115,583)		1,967
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)					498,000
Exercise of options/ B1 warrants	554				$ 1							553
Exercise of options to common- unissued	3											3
Distribution to noncontrolling shareholder	(380)																(380)
Adjustment of redeemable non controlling interest	0											29			(29)
Share based compensation expense	324											324
Conversion of Series A Preferred stock to common (in shares)					10,164,000	381,000				(381,000)
Conversion of Series A Preferred stock to common	59,822	$ 1			$ 10	$ 1						59,812
Accretion of redeemable non-controlling interest to redemption value	(6)														(6)
Net income (loss)	(63,782)														(66,970)		3,188
Less: amount attributable to redeemable non-controlling interest	(3,023)																(3,023)
Ending balance (in shares) at Jun. 30, 2022					75,509,000				0		0
Ending balance at Jun. 30, 2022	$ 97,695				$ 76				$ 0		$ 0	$ 278,455			$ (182,588)		$ 1,752